Whole-mount immunolabeling enabled high-resolution visualization of peripheral nerve infiltration patterns within melanoma, ...

The company will use the funds to accelerate its clinical programs and prepare for commercialization of its neuromodulation ...

Nerve fibers within melanomas can slow their growth, according to a study led by Weill Cornell Medicine investigators. The ...

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the company will be ...

Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the closing of an oversubscribed $52.5 million ...

Nervonik announced today that it closed an oversubscribed Series B financing round worth proceeds of $52.5 million.

Leg tingling, numbness, pain, and cramping can be easy to dismiss, but they may point to circulation problems such as ...

Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...

This healthcare firm develops nerve repair solutions for hospitals and specialists in the U.S. and select global markets.

However, a new study has identified a surprising “brake.” Investigating melanoma in mouse models, the team discovered that sympathetic nerves, the same ones responsible for the “fight-or-flight” ...

Nervonik raises $52.5M in Series B funding to advance its peripheral nerve stimulation technology and expand innovative ...

Nervonik has secured $52.5 million in Series B funding to accelerate development and commercialization of its peripheral nerve stimulation platform, which integrates real-time sensing for precise pain ...